CorVista Health appoints Anjali Tiku Owens to medical advisory board

CorVista Health, Inc. announces expansion of their Medical Advisory Board with the appointment of Dr Anjali Tiku Owens.

Anjali Tiku Owens, M.D., is an Associate Professor of Medicine in the Division of Cardiology, Section of Heart Failure and Transplantation at the Perelman School of Medicine of the University of Pennsylvania. She is the founding Director of the Penn Familial Cardiomyopathy Program, Director of the Hypertrophic Cardiomyopathy clinic and was appointed the Medical Director of the Penn Center for Inherited Cardiovascular Disease in 2015. She has a special interest in novel therapies for genetic cardiomyopathy.

“As we near commercialization of our first indication of the CorVista System for Coronary Artery Disease (CAD), it is essential we continue to bring cardiovascular experts onboard our Medical Advisory Board. We are thrilled to welcome Dr Anjali Tiku Owens to our esteemed board,” said Don Crawford, President and CEO of CorVista Health. “Dr Tiku Owens’ wealth of experience and expertise in cardiology, particularly in genetic cardiomyopathy and novel therapies, will be invaluable as we work to revolutionize cardiovascular care.”

Dr Tiku Owens joins a distinguished group of medical professionals on the CorVista Health Medical Advisory Board, contributing to the company’s mission to improve the availability and accessibility of cardiovascular disease diagnosis. The announcement follows the recent FDA clearance of the CorVista System with CAD Add-On.

“I am honored to join CorVista Health’s Medical Advisory Board and contribute to the advancement of cardiovascular care,” said Dr Anjali Tiku Owens, M.D., Associate Professor of Medicine, University of Pennsylvania. “The CorVista System holds immense promise in transforming how we diagnose and treat cardiovascular diseases. I look forward to collaborating with CorVista and the Medical Advisory Board to make a meaningful impact on patient outcomes.”
MB Bureau